How to avoid time-related types of bias in the analysis of clinical infectious diseases: demonstration and methods
- PMID: 40222555
- DOI: 10.1016/j.cmi.2025.04.005
How to avoid time-related types of bias in the analysis of clinical infectious diseases: demonstration and methods
Abstract
Background: Competing risk and immortal time bias can significantly affect the interpretation of analyses in infection disease research where patients may experience multiple outcomes. These biases can distort study results, leading to misestimation of event rates or therapy effects, and ultimately misinform clinical decisions.
Objective: This article aims to explain the concepts of competing risk and immortal time bias while providing a clear understanding of how these biases arise and offering practical methods for addressing them in clinical studies. A study of patients in the intensive care unit (ICU) is used as an illustrative example.
Sources: References were compiled through searches of MEDLINE/PubMed and Google Scholar up to December 2024.
Content: Competing risk bias occurs when a patient is at risk for more than one mutually exclusive event, such as death from different causes, which can skew survival analyses if not properly accounted for. Immortal time bias arises when periods during which the outcome cannot occur for patients with an intermediate exposure are improperly included in a survival analysis. This leads to altered effects and duration of stay estimation. In the ICU data example, ignoring competing risks results in impossible probability estimates and relative overestimation of incidence by as much as 52%. Ignoring time dependencies leads to the flawed conclusion that bloodstream infection is protective against patient death in the ICU, whereas a valid approach results in a significant harmful effect. Solutions such as multi-state models or extended Cox regression models are presented to mitigate these biases. Examples from published literature with proper handling of these biases are provided.
Implications: Properly accounting for competing risk and immortal time biases ensures more reliable and valid results, ultimately guiding better clinical decision-making and improving patient outcomes in the management of infectious diseases.
Keywords: Bias mitigation; Common mistakes; Competing risk bias; Cox regression; Immortal time bias; Methodological pitfalls; Multi-state model; Survival analysis.
Copyright © 2025 The Authors. Published by Elsevier Ltd.. All rights reserved.
Similar articles
-
Methodological biases in observational hospital studies of COVID-19 treatment effectiveness: pitfalls and potential.Front Med (Lausanne). 2024 Mar 21;11:1362192. doi: 10.3389/fmed.2024.1362192. eCollection 2024. Front Med (Lausanne). 2024. PMID: 38576716 Free PMC article.
-
The future of Cochrane Neonatal.Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12. Early Hum Dev. 2020. PMID: 33036834
-
Target Trial Emulation Using Hospital-Based Observational Data: Demonstration and Application in COVID-19.Life (Basel). 2023 Mar 13;13(3):777. doi: 10.3390/life13030777. Life (Basel). 2023. PMID: 36983933 Free PMC article.
-
Methodological evaluation of bias in observational coronavirus disease 2019 studies on drug effectiveness.Clin Microbiol Infect. 2021 Jul;27(7):949-957. doi: 10.1016/j.cmi.2021.03.003. Epub 2021 Apr 1. Clin Microbiol Infect. 2021. PMID: 33813117 Free PMC article.
-
Target trial emulation framework: mitigating methodological challenges and application in COVID-19 treatment evaluation studies.Clin Microbiol Infect. 2025 Apr 29:S1198-743X(25)00190-9. doi: 10.1016/j.cmi.2025.04.027. Online ahead of print. Clin Microbiol Infect. 2025. PMID: 40311676 Review.
Publication types
LinkOut - more resources
Full Text Sources